rapid ID 32 A

GUDID 03573026066420

rapid ID 32 A is a standardized system for the identification of anaerobes in 4 hours

BIOMERIEUX SA

Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit Multiple anaerobic bacteria species culture isolate identification IVD, kit

• Primary Device ID: 03573026066420
• NIH Device Record Key: 9e8c288b-b368-417a-a00b-8bc1c42cf16a
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: rapid ID 32 A
• Version Model Number: rapid ID 32 A
• Company DUNS: 276816717
• Company Name: BIOMERIEUX SA
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: true
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	03573026066420 [Package]; Contains: 03573026588564; Package: [25 Units]; In Commercial Distribution
GS1	03573026588564 [Primary]

FDA Product Code

• JSP: KIT, ANAEROBIC IDENTIFICATION

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2020-04-20
• Device Publish Date: 2020-04-10

Devices Manufactured by BIOMERIEUX SA

• 03573026256685 - ETEST® Gentamicin (GM): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026376604 - ETEST® Amoxicillin (AC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026377731 - ETEST® Flucytosine (FC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions
• 03573026560690 - ETEST® Meropenem/Vaborbactam (MEV): 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an
• 03573026475352 - ETEST® Telavancin (TLA): 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026252526 - ETEST® Cefepime (PM): 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026253219 - Etest® TIC/CLAV-CON2: 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026617851 - VITEK®MS: 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument